What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Genetics
The scientist’s investigation covers issues in Genetics, Allele, Internal medicine, Psychiatry and Schizophrenia.
His study in Haplotype, Transmission disequilibrium test, Gene, Linkage disequilibrium and Genome-wide association study is carried out as part of his Genetics studies.
His Allele research incorporates elements of Locus and Genotype.
In his study, Clozapine and Receptor is strongly linked to Endocrinology, which falls under the umbrella field of Internal medicine.
His Psychiatry research is multidisciplinary, incorporating perspectives in Overeating, Dopamine receptor D2 and Clinical psychology.
His work deals with themes such as Bipolar disorder, Genetic heterogeneity, Psychosis and Pharmacogenetics, which intersect with Schizophrenia.
His most cited work include:
- Biological insights from 108 schizophrenia-associated genetic loci (4834 citations)
- Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs (1570 citations)
- West of Scotland Coronary Prevention Study: Identification of high-risk groups and comparison with other cardiovascular intervention trials (1513 citations)
What are the main themes of his work throughout his whole career to date?
Genetics, Internal medicine, Schizophrenia, Psychiatry and Endocrinology are his primary areas of study.
His Genetics study often links to related topics such as Psychosis.
His biological study spans a wide range of topics, including Genetic determinism and Genetic linkage.
His research integrates issues of Bipolar disorder, Polymorphism, Neuroscience and Oncology in his study of Internal medicine.
His studies in Schizophrenia integrate themes in fields like Pharmacogenetics and Pharmacology.
James L. Kennedy has researched Allele in several fields, including Attention deficit hyperactivity disorder, Genotype and Candidate gene.
He most often published in these fields:
- Genetics (46.57%)
- Internal medicine (34.49%)
- Schizophrenia (35.36%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (34.49%)
- Schizophrenia (35.36%)
- Pharmacogenetics (16.33%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Schizophrenia, Pharmacogenetics, Genome-wide association study and Clinical psychology.
His Internal medicine research incorporates themes from Antidepressant, Endocrinology, Depression, Late life depression and Oncology.
James L. Kennedy has included themes like Genetics, Gene, Single-nucleotide polymorphism and Pharmacology in his Schizophrenia study.
His work in Candidate gene and Allele is related to Genetics.
His Pharmacogenetics study also includes fields such as
- Antipsychotic which is related to area like Schizoaffective disorder, Bioinformatics, Weight gain and Weight change,
- Abnormal Involuntary Movement Scale most often made with reference to Tardive dyskinesia.
James L. Kennedy interconnects Eating disorders, Psychiatry, Bipolar disorder, Genetic association and Genetic architecture in the investigation of issues within Genome-wide association study.
Between 2018 and 2021, his most popular works were:
- Genome-wide association study identifies 30 loci associated with bipolar disorder (518 citations)
- Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders (242 citations)
- Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa (208 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Genetics
James L. Kennedy focuses on Schizophrenia, Pharmacogenetics, Clinical psychology, Internal medicine and Major depressive disorder.
His work carried out in the field of Schizophrenia brings together such families of science as Psychosis, Genome-wide association study and Weight change.
His Genome-wide association study research includes elements of Bipolar disorder, Genetic association and Genetic architecture.
Pharmacogenetics is a primary field of his research addressed under Genetics.
A large part of his Genetics studies is devoted to Exome sequencing.
His Internal medicine research integrates issues from CYP2C19, Endocrinology, Mitochondrion and Oncology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
